Dr. Mehdi M. Moezi, MD
- Medicare services, 2024
- 106,268
- Medicare patients, 2024
- 949
- Part D claims, 2024
- 1,166
- Publications
- 5
- Clinical trials
- 6
- Practice address
- 7015 A C Skinner Pkwy, Jacksonville, FL 32256
- Practice phone
- Call (904) 363-2113
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Cancer Specialists of North Florida
Jacksonville, Florida
Find Dr. Moezi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mehdi M. Moezi is a hematologist and oncologist in Jacksonville, Florida
Dr. Moezi practices at Cancer Specialists of North Florida in Jacksonville, Florida.
Dr. Moezi's NPI, 1053316190, was assigned on June 16, 2005. Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990. Dr. Moezi holds Florida license ME80061.
- NPI
- 1053316190NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4688625221
- NPI enumeration date
- June 16, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (904) 363-2113
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 62
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mehdi M. Moezi practices at Cancer Specialists of North Florida in Jacksonville, Florida
Dr. Moezi's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.
- Cancer Specialists of North Florida7015 A C Skinner Pkwy, Jacksonville, FL 32256 · Duval CountyPhone(904) 363-2113
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mehdi M. Moezi is affiliated with 6 sites of care and 1 medical group
Dr. Moezi's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Moezi is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Moezi to 3 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Mehdi M. Moezi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moezi practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Cancer Specialists of North Florida | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mehdi M. Moezi is one of 693 hematologists and oncologists in Florida
Hematology and oncology is Dr. Moezi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Moezi is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Moezi's licenses on file in 3 states: Florida, California and Utah.
Specialties and state licenses
- Hematology and oncology, FloridaPrimary
- California license
- Utah license
Clinical focus
Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances and immune deficiency disease among the conditions Dr. Moezi treats.
Hematologists and oncologists near Dr. Moezi
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mehdi M. Moezi billed Medicare for 106,268 services in 2024
CMS data shows 106,268 Medicare services from Dr. Moezi across 50 procedure codes in 2024, for 949 Medicare patients. Medicare paid $895,652 for them.
Dr. Moezi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 43,0722024: 50,89318%
- Drugs given in the office
- 2023: 51,3832024: 48,6135%
- Imaging
- 2023: 1,4462024: 1,65514%
- Lab and pathology
- 2023: 1,7442024: 1,6396%
- Surgery
- 2023: 1,5132024: 1,31813%
- Tests and treatments
- 2023: 1,6302024: 1,23824%
- Office and hospital visits
- 2023: 9842024: 9127%
Where Dr. Moezi's Medicare services took place, 2024
- In an office106,221100%
- In a facility470%
Dr. Moezi compared with the Florida median for hematologists and oncologists, 2024
- Dr. Moezi
- Florida median
- Medicare services
- 106,268vs 697152.5 times
- Medicare patients
- 949vs 2184.4 times
- Part D claims
- 927vs 3412.7 times
Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Moezi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Moezi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Moezi and other hematologists and oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mehdi M. Moezi treated 949 Medicare patients in 2024, average age 75
CMS counts 949 Medicare patients who saw Dr. Moezi in 2024. The largest group is 65 to 74, with 406 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Moezi's median patient age at 70, with 58% women.
Dr. Moezi's Medicare patients by age, 2024
Dr. Moezi's Medicare patients by sex, 2024
- Women53056%
- Men41944%
Chronic conditions among Dr. Moezi's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis52%
- Cancer48%
- Ischemic heart disease45%
- Chronic kidney disease39%
- Diabetes39%
- COPD33%
Share of Medicare patients with each condition. A patient can have several.
Dr. Moezi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women58%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mehdi M. Moezi wrote 1,166 Medicare Part D claims in 2024
In 2024, Dr. Moezi wrote 1,166 Medicare Part D claims for 192 patients. 73% of them were for generic drugs. CMS names the drug for 927 of them, across 36 drugs with 11 or more claims each, at $1,871,820 in total drug cost. In 2023, CMS named 734 claims across 27 drugs.
Dr. Moezi's Part D claims by kind of drug, 2024
- Generic846 claims73%
- Brand-name320 claims27%
Dr. Moezi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Moezi's Part D claims, 2024
- Opioids8%98 of 1,166 claims
- Antibiotics5%55 of 1,166 claims
- Antipsychotics, patients 65 and over1%11 of 1,166 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7342024: 92726%
Drugs named by CMS: 36 in 2024, 27 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Mehdi M. Moezi takes part in Medicare
Dr. Moezi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mehdi M. Moezi has 5 publications on record
Dmand AI links 5 papers to Dr. Moezi, published from 2012 to 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Carboplatin and Etoposide. Dr. Moezi's most frequent co-authors are Helen J. Ross, MD, Marshall T. Schreeder, MD and Laura Johnetta Blakely, MD.
Dr. Moezi's papers by year, 2012 to 2024
Topics Dr. Moezi writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Carboplatin
- Etoposide
- Indoles
- Lung Neoplasms
- Pyrroles
- Small Cell Lung Carcinoma
Dr. Moezi's most frequent co-authors
- Helen J. Ross, MD2 shared papers
- Marshall T. Schreeder, MD2 shared papers
- Laura Johnetta Blakely, MD1 shared paper
Recent publications by Dr. Moezi
See who Dr. Moezi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Moezi works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mehdi M. Moezi has worked on 6 clinical trials
Dmand AI links Dr. Moezi to 6 clinical trials, 5 of them phase 3 studies. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Anemia, Refractory, with Excess of Blasts. Bristol-Myers Squibb sponsors the most, 2.
Clinical trials with Dr. Moezi by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Moezi's trials
- Multiple Myeloma
- Blood Protein Disorders
- Anemia, Refractory, with Excess of Blasts
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Follicular
Investigators on the most trials with Dr. Moezi
- Robert Andrew Dichmann, MD2 shared trials
- Charles M. Farber, MD, PhD2 shared trials
- Roger M. Lyons, MD2 shared trials
Recent clinical trials with Dr. Moezi
Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mehdi M. Moezi received $157,916 in industry payments from 2016 to 2025
CMS Open Payments shows 534 general payments to Dr. Moezi from 56 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Bristol-Myers Squibb Company paid the most, $49,304. It also lists 4 research payments totaling $7,670 from 2022 to 2024.
General payments to Dr. Moezi by program year, 2016 to 2025
General payments to Dr. Moezi by kind, 2016 to 2025
- Speaker and faculty fees$68,60043%
- Consulting fees$49,89732%
- Travel and lodging$29,45619%
- Food and beverage$9,4346%
- Education$5290%
Companies that paid Dr. Moezi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mehdi M. Moezi has 1 award and honors on record
Dmand AI lists 1 award for Dr. Moezi, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Moezi
- 2013
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Mehdi M. Moezi graduated from Tehran University of Medical Sciences School of Medicine
Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990. Dr. Moezi is a member of ACP, AMA, ASCO, ASH and European Society of Medical Oncology.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Mehdi M. Moezi accepts plans from 18 insurance carriers
Dr. Moezi is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
- Aetna
- United Healthcare
- Elevance
- HCSC
- Humana
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Blue Cross Blue Shield of Michigan
- +10 more carriersWith a free account
Plan types Dr. Moezi accepts, by number of carriers
- PPO11
- HMO8
- Medicare7
- EPO4
- POS3
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Mehdi M. Moezi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mehdi M. Moezi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mehdi M. Moezi's NPI number?
Dr. Mehdi M. Moezi's NPI number is 1053316190. It was assigned on June 16, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Mehdi M. Moezi?
Dr. Mehdi M. Moezi is a hematologist and oncologist in Jacksonville, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mehdi M. Moezi practice?
Dr. Moezi practices at 7015 A C Skinner Pkwy, Jacksonville, FL 32256. Dr. Moezi's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dmand AI also links Dr. Moezi to 3 hospitals and 1 group practice or clinic.
What is Dr. Mehdi M. Moezi's office phone number?
The practice phone on file for Dr. Moezi is (904) 363-2113.
What is Dr. Mehdi M. Moezi's medical license number?
Dr. Moezi holds Florida license ME80061, one of the licenses on file in 3 states.
Which states has Dr. Mehdi M. Moezi been licensed in?
Dmand AI has state licenses on file for Dr. Moezi in Florida (2000 to 2026), California (since 2005) and Utah (1998 to 2006).
Which hospitals is Dr. Mehdi M. Moezi affiliated with?
Dr. Moezi is affiliated with Baptist Medical Center Jacksonville. Dmand AI links Dr. Moezi to 3 more hospitals.
What medical group is Dr. Mehdi M. Moezi part of?
Dr. Moezi is linked to Cancer Specialists of North Florida.
Does Dr. Mehdi M. Moezi accept Medicare?
Yes. CMS data shows Dr. Moezi billed Medicare for 106,268 services in 2024, and Dr. Moezi accepts Medicare assignment.
How many Medicare patients does Dr. Mehdi M. Moezi see?
CMS counts 949 Medicare patients who saw Dr. Moezi in 2024, with an average age of 75.
Show 9 more questionsShow fewer questions
Is Dr. Mehdi M. Moezi board certified?
Yes. Dr. Moezi is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Mehdi M. Moezi bill to Medicare?
In 2024, Dr. Moezi's most billed Medicare services were medicare temporary code (Q9967), injected or infused drug (J1439) and medical supplies or transport (A9575).
Where did Dr. Mehdi M. Moezi go to medical school?
Dr. Moezi graduated from Tehran University of Medical Sciences School of Medicine in 1990.
What drugs does Dr. Mehdi M. Moezi prescribe most?
In 2024 Medicare Part D data, Dr. Moezi's most prescribed drugs by claims were Letrozole, Eliquis and Ibandronate Sodium.
Has Dr. Mehdi M. Moezi received payments from drug or device companies?
CMS Open Payments shows $157,916 in general payments to Dr. Moezi from 56 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Mehdi M. Moezi been practicing?
Dr. Moezi graduated from medical school in 1990, 36 years ago.
Does Dr. Mehdi M. Moezi do research?
Dmand AI links 5 publications to Dr. Moezi, published from 2012 to 2024. Dr. Moezi has worked on 6 clinical trials.
Who does Dr. Mehdi M. Moezi publish with?
Dr. Moezi's most frequent co-authors are Helen J. Ross, MD (2 shared papers), Marshall T. Schreeder, MD (2 shared papers) and Laura Johnetta Blakely, MD (1 shared paper).
What insurance does Dr. Mehdi M. Moezi accept?
Dr. Moezi is in network with 18 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card